journal article·2024-10-11

Enhanced Oral Delivery of Insulin via Loading in Polysorbate-80 Micelles

Rujing Xu, Ying Lu, Mengxiao Liu, Yanzhao Yin, Junsheng Zhao, Lin Wu, Song Shen

ACS Applied Nano Materials· Volume 7· Issue 19
Publisher page

Abstract

Oral delivery of insulin exhibits low bioavailability due to the hydrolysis in acidic gastric juice, biodegradation of enzymes, and inefficient penetration through the intestinal mucus and epithelial cell layer. Here, we report a micelle platform to enhance the oral delivery of insulin. Insulin was precipitated by zinc ions to form hydrophobic nanoparticles and subsequently coated with a surfactant polysorbate-80 (Tween-80) to form nanosized micelles (TW-Zn-rhINS). Tween-80 protects the insulin from the degradation of enzymes, meanwhile facilitating the diffusion within mucus and the epithelial cell layer by opening the tight junctions. The micelles were then lyophilized and encapsulated in enteric capsules to overcome acidic hydrolysis in gastric juice. The micelles significantly increased transcellular insulin transport and uptake. The in vivo experiments demonstrated that oral TW-Zn-rhINS micelle capsules (30 IU/kg) decreased the blood glucose of diabetic mice by 58.74% after administration for 6 h, while the postprandial blood glucose dropped by 51.1%. Pharmacokinetics data indicated that the relative oral bioavailability of TW-Zn-rhINS was 7.88%, which was 7.73 times higher than that of insulin. The micelles present a promising platform to enhance the oral bioavailability of insulin, also indicating a potential for oral delivery of protein.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Protein purification and stability

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China

Zhenjiang Mental Health Center, Zhenjiang 212001, China

Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China

Funding

National Natural Science Foundation of China

References (28)

Show source-provided references
1. 10.1016/j.diabres.2021.10911910.1016/j.diabres.2021.109119 ↗
2. 10.1016/j.ijbiomac.2023.12511410.1016/j.ijbiomac.2023.125114 ↗
3. 10.1021/jacs.1c1342610.1021/jacs.1c13426 ↗
4. 10.1080/09205063.2022.209652710.1080/09205063.2022.2096527 ↗
5. 10.1016/j.addr.2011.12.00910.1016/j.addr.2011.12.009 ↗
6. 10.1016/j.jconrel.2021.11.02010.1016/j.jconrel.2021.11.020 ↗
7. 10.1016/j.jconrel.2023.12.04510.1016/j.jconrel.2023.12.045 ↗
8. 10.1016/j.cclet.2023.10817710.1016/j.cclet.2023.108177 ↗
9. 10.1038/s41565-020-0693-610.1038/s41565-020-0693-6 ↗
10. 10.1038/s41565-023-01561-610.1038/s41565-023-01561-6 ↗
11. 10.1038/s41565-023-01565-210.1038/s41565-023-01565-2 ↗
12. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
13. 10.3109/10717544.2010.52035510.3109/10717544.2010.520355 ↗
14. 10.1016/j.xphs.2016.01.01610.1016/j.xphs.2016.01.016 ↗
15. 10.1021/cr020661+10.1021/cr020661+ ↗
16. 10.1016/j.ijpharm.2016.08.04510.1016/j.ijpharm.2016.08.045 ↗
17. 10.1080/10717544.2016.124537010.1080/10717544.2016.1245370 ↗
18. 10.1038/aps.2010.5510.1038/aps.2010.55 ↗
19. 10.1016/j.ijpharm.2022.12170610.1016/j.ijpharm.2022.121706 ↗
20. 10.1080/10717544.2019.169296810.1080/10717544.2019.1692968 ↗
21. 10.1021/acsami.6b0818310.1021/acsami.6b08183 ↗
22. 10.1002/jps.1017610.1002/jps.10176 ↗
23. 10.1016/j.jconrel.2006.12.00310.1016/j.jconrel.2006.12.003 ↗
24. 10.1021/acsomega.2c0441910.1021/acsomega.2c04419 ↗
25. 10.1016/j.ejpb.2012.02.00910.1016/j.ejpb.2012.02.009 ↗
26. 10.1016/j.abb.2017.04.00510.1016/j.abb.2017.04.005 ↗
27. 10.1038/s41467-022-34357-810.1038/s41467-022-34357-8 ↗
28. 10.1016/j.addr.2021.11409710.1016/j.addr.2021.114097 ↗